China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
The current price of CHME is $0.02 USD — it has increased by +0% in the past 24 hours. Watch China Medicine stock price performance more closely on the chart.
What is China Medicine stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange China Medicine stocks are traded under the ticker CHME.
What were China Medicine earnings last quarter?▼
CHME earnings for the last quarter are 0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does China Medicine have?▼
As of April 02, 2026, the company has 281 employees.
In which sector is China Medicine located?▼
China Medicine operates in the Health Care sector.
When did China Medicine complete a stock split?▼
China Medicine has not had any recent stock splits.